Propanc Biopharma Ord Shs

Important metrics include cash and short-term investments, total assets, current assets, total liabilities, current liabilities, long-term debt, shareholders' equity, retained earnings, inventory, receivables, working capital, current ratio, quick ratio, debt-to-equity ratio, and return on equity. Investors usually review these together rather than relying on one number.

Assets are resources the company owns or controls, such as cash, receivables, inventory, investments, and property. Liabilities are obligations the company owes, such as accounts payable, debt, leases, and taxes. Shareholders' equity is the residual value after liabilities are subtracted from assets.

Current assets and current liabilities are generally expected to be converted, used, paid, or settled within one year or one operating cycle. Non-current assets and non-current liabilities are longer-term items, such as property, long-term investments, deferred tax assets, long-term debt, and lease obligations.

In its most recent quarterly, Propanc Biopharma Ord Shs had 443.70K in cash and cash equivalents.

Propanc Biopharma Ord Shs reported 5.73M in total liabilities as of the latest reported quarter, including 5.58M in current liabilities and 147.38K in non-current liabilities.

As of the latest reported quarter, Propanc Biopharma Ord Shs's total assets were 19.63M, consisting of 8.35M in current assets and 11.28M in non-current assets.

Propanc Biopharma Ord Shs reported 13.91M in total shareholders' equity as of the latest reported quarter.